title: Caffeine attenuates the action of amsacrine and etoposide in U-937 cells by mechanisms which involve inhibition of RNA synthesis.
abstract: Pulse treatments of U-937 human promonocytic leukemia cells with the DNA topoisomerase-II inhibitors 4'-(9-acridynilamino)methanesulfon-m-anisidide (amsacrine, mAMSA) or etoposide (VP-16) caused growth inhibition, G2-arrest, increase in cell size and expression of differentiation markers. All these effects were greatly reduced by the presence of 5-10 mM caffeine. In addition, caffeine partially prevented the increase in the number of topoisomerase-DNA cleavable complexes caused by the topoisomerase inhibitors, as determined by SDS/CIK precipitation assays; it caused chromatin condensation, as determined by flow cytometry assays, and interacted with mAMSA in solution, as suggested by spectrophotometric assays. Pulse treatment with caffeine greatly inhibited RNA synthesis but not DNA or protein synthesis, as indicated by labelled precursor incorporation assays. The transcription inhibitor 5,6-dichloro-I-beta-D-ribofuranosylbenzymidazole reduced the mAMSA- and VP-16-produced growth inhibition in a similar manner. It is concluded that RNA synthesis inhibition is one of the possible mechanisms by which caffeine protects cells from the action of topoisomerase-II inhibitors.
authors.affiliation: Instituto de Química Médica, CSIC, Madrid, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Pérez
authors.forename: F
authors.initials: F
authors.lastname: Pelayo
authors.forename: N E
authors.initials: NE
authors.lastname: Vilaboa
authors.forename: P
authors.initials: P
authors.lastname: Aller
mesh_terms: D000677:Amsacrine / Q000008:administration & dosage*; D002110:Caffeine / Q000008:administration & dosage*; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002843:Chromatin / Q000648:ultrastructure; D004250:DNA Topoisomerases, Type II / Q000378:metabolism; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004268:DNA-Binding Proteins / Q000378:metabolism; D005047:Etoposide / Q000008:administration & dosage*; D006801:Humans; D066298:In Vitro Techniques; D009363:Neoplasm Proteins / Q000096:biosynthesis; D012334:RNA, Neoplasm / Q000096:biosynthesis*; D014407:Tumor Cells, Cultured
chemical_list: D002843:Chromatin; D004273:DNA, Neoplasm; D004268:DNA-Binding Proteins; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D000677:Amsacrine; D002110:Caffeine; D005047:Etoposide; D004250:DNA Topoisomerases, Type II